Durable Capital Partners LP cut its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 54.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 478,706 shares of the company's stock after selling 570,456 shares during the quarter. Durable Capital Partners LP owned 0.84% of Molina Healthcare worth $139,327,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Colonial Trust Co SC grew its stake in shares of Molina Healthcare by 930.0% in the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after purchasing an additional 93 shares during the last quarter. Versant Capital Management Inc grew its position in Molina Healthcare by 83.1% in the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after buying an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. bought a new position in shares of Molina Healthcare in the fourth quarter valued at $52,000. Hurley Capital LLC acquired a new stake in shares of Molina Healthcare during the 4th quarter valued at $55,000. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after acquiring an additional 88 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the company. Truist Financial upped their target price on Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a report on Friday, April 11th. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their price objective for the company from $295.00 to $372.00 in a research note on Wednesday, March 5th. Stephens reissued an "equal weight" rating and issued a $345.00 target price on shares of Molina Healthcare in a research report on Thursday, February 6th. Baird R W downgraded shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Finally, Mizuho lifted their price objective on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Nine equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $365.38.
Check Out Our Latest Stock Analysis on Molina Healthcare
Insider Transactions at Molina Healthcare
In related news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the transaction, the director now directly owns 17,375 shares in the company, valued at $5,235,608.75. This represents a 5.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the sale, the chief executive officer now owns 257,715 shares in the company, valued at $82,484,262.90. This represents a 25.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 89,169 shares of company stock worth $28,520,995 over the last three months. 1.10% of the stock is currently owned by insiders.
Molina Healthcare Stock Down 0.6 %
Molina Healthcare stock traded down $2.02 during mid-day trading on Friday, hitting $323.84. 602,871 shares of the company's stock were exchanged, compared to its average volume of 681,091. The stock has a market cap of $17.55 billion, a P/E ratio of 15.85, a P/E/G ratio of 1.06 and a beta of 0.63. The stock has a 50 day moving average of $324.73 and a two-hundred day moving average of $308.25. Molina Healthcare, Inc. has a 1-year low of $262.32 and a 1-year high of $365.23. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating the consensus estimate of $5.96 by $0.12. The company had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The company's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter last year, the company posted $5.73 earnings per share. As a group, analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.